U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    FGD1 FYVE, RhoGEF and PH domain containing 1 [ Homo sapiens (human) ]

    Gene ID: 2245, updated on 27-Nov-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Novel truncating variants in FGD1 detected in two Danish families with Aarskog-Scott syndrome and myopathic features.

    Novel truncating variants in FGD1 detected in two Danish families with Aarskog-Scott syndrome and myopathic features.
    Bayat A, Krett B, Dunø M, Torring PM, Vissing J., Free PMC Article

    06/18/2022
    Silencing FYVE, RhoGEF, and PH domain containing 1 (FGD1) suppresses melanoma progression by inhibiting PI3K/AKT signaling pathway.

    Silencing FYVE, RhoGEF, and PH domain containing 1 (FGD1) suppresses melanoma progression by inhibiting PI3K/AKT signaling pathway.
    Niu Z, Li Y, Xu Y, Jiang W, Tao R, Chen Y, Han Y., Free PMC Article

    02/19/2022
    A novel truncating variant in the FGD1 gene associated with Aarskog-Scott syndrome in a family previously diagnosed with Tel Hashomer camptodactyly.

    A novel truncating variant in the FGD1 gene associated with Aarskog-Scott syndrome in a family previously diagnosed with Tel Hashomer camptodactyly.
    Kessel I, German A, Peleg A, Regeneron Genetics Center, Gonzaga-Jauregui C, Paperna T, Ekhilevitch N, Kurolap A, Baris Feldman H, Sagi-Dain L.

    01/22/2022
    Xp11.22 duplications in four unrelated Chinese families: delineating the genotype-phenotype relationship for HSD17B10 and FGD1.

    Xp11.22 duplications in four unrelated Chinese families: delineating the genotype-phenotype relationship for HSD17B10 and FGD1.
    Wang Q, Chen P, Liu J, Lou J, Liu Y, Yuan H., Free PMC Article

    05/15/2021
    FGD1 promotes tumor progression and regulates tumor immune response in osteosarcoma via inhibiting PTEN activity.

    FGD1 promotes tumor progression and regulates tumor immune response in osteosarcoma via inhibiting PTEN activity.
    Wu W, Jing D, Meng Z, Hu B, Zhong B, Deng X, Jin X, Shao Z., Free PMC Article

    05/15/2021
    Intersection of TKS5 and FGD1/CDC42 signaling cascades directs the formation of invadopodia.

    Intersection of TKS5 and FGD1/CDC42 signaling cascades directs the formation of invadopodia.
    Zagryazhskaya-Masson A, Monteiro P, Macé AS, Castagnino A, Ferrari R, Infante E, Duperray-Susini A, Dingli F, Lanyi A, Loew D, Génot E, Chavrier P., Free PMC Article

    03/27/2021
    Sequencing analyses in numerous types of cancer have found missense mutations in the FGD1 gene in metastatic tumors.

    Minireview: Role of genetic changes of faciogenital dysplasia protein 1 in human disease.
    Pedigo NG, Van Delden D, Walters L, Farrell CL.

    01/27/2018
    A novel variant in FGD1 (a novel hemizygous mutation in FGD1 c.53del (p.Pro18Argfs*106) for which the mother is heterozygous) was found in an Emirati family with two brothers suffering from Aarskog-Scott syndrome. The variant is predicted to be a null mutation, and this is the first report of its kind from the United Arab Emirates.

    A novel, putatively null, FGD1 variant leading to Aarskog-Scott syndrome in a family from UAE.
    Hamzeh AR, Saif F, Nair P, Binjab AJ, Mohamed M, Al-Ali MT, Bastaki F., Free PMC Article

    12/30/2017
    Splice site mutation of FGD1 gene is associated with Aarskog-Scott syndrome patient with a large anterior fontanel.

    A novel splice site mutation of FGD1 gene in an Aarskog-Scott syndrome patient with a large anterior fontanel.
    Parıltay E, Hazan F, Ataman E, Demir K, Etlik Ö, Özbek E, Özkan B.

    05/6/2017
    Results identify a novel mutation of FDG1 in a family with Aarskog syndrome and underscore the phenotypical variability of this condition.

    Aarskog-Scott syndrome: a novel mutation in the FGD1 gene associated with severe craniofacial dysplasia.
    Völter C, Martínez R, Hagen R, Kress W.

    05/30/2015
    No significant association was observed between IDD and allele or genotype frequencies, or the haplotype of the 5 SNPs of the FGD1 gene in the Chinese population.

    No association between FGD1 gene polymorphisms and intellectual developmental disability in the Qinba mountain area.
    Li JL, Li YJ, Zhang KJ, Lan L, Shi JG, Yang X, Zhang MJ, Zhang FC, Gao XC.

    09/27/2014
    branch point variant in FGD1 identified by exome sequencing in Aarskog-Scott syndrome

    Exome sequencing identifies a branch point variant in Aarskog-Scott syndrome.
    Aten E, Sun Y, Almomani R, Santen GW, Messemaker T, Maas SM, Breuning MH, den Dunnen JT.

    08/31/2013
    Mutational analyses revealed a novel mutation (c.308-2G), hemizygous in the boy and heterozygous in the mother with Aarskog syndrome.

    A novel mutation in a mother and a son with Aarskog-Scott syndrome.
    Altıncık A, Kaname T, Demir K, Böber E.

    08/10/2013
    A novel mutation in exon 6 (G1341A substituting tryptophan with a stop codon at amino acid position 447) may have influenced the clinical phenotype of these 5 patients with Aarskog-Scott syndrome.

    Novel FGD1 mutation underlying Aarskog-Scott syndrome with myopathy and distal arthropathy.
    Al-Semari A, Wakil SM, Al-Muhaizea MA, Dababo M, Al-Amr R, Alkuraya F, Meyer BF.

    05/18/2013
    Authors discuss the hypothesis that FGD1 might be an important regulator of events controlling extracellular matrix remodelling and possibly cell invasion in physiological and pathological settings.

    FGD1 as a central regulator of extracellular matrix remodelling--lessons from faciogenital dysplasia.
    Genot E, Daubon T, Sorrentino V, Buccione R.

    03/30/2013
    The faciogenital dysplasia 1 (FGD1)gene encodes for a protein involved in skeletal and neuronal development.

    X-linked Aarskog syndrome: report on a novel FGD1 gene mutation. Executive dysfunction as part of the behavioural phenotype.
    Verhoeven WM, Egger JI, Hoogeboom AJ.

    09/1/2012
    This is the first report of inheritance by germline mosaicism for the FGD1 gene

    Fraternal twins with Aarskog-Scott syndrome due to maternal germline mosaicism.
    Pilozzi-Edmonds L, Maher TA, Basran RK, Milunsky A, Al-Thihli K, Braverman NE, Alfares A.

    11/26/2011
    These results demonstrate an important role for FGD1/Cdc42 signaling in human mesenchymal stem cells osteogenesis.

    The Cdc42 guanine nucleotide exchange factor FGD1 regulates osteogenesis in human mesenchymal stem cells.
    Gao L, Gorski JL, Chen CS., Free PMC Article

    05/28/2011
    This study showed that the proline-rich doman of FGD1 is critical for persistent cell migration; FGD1 also augments EGF-stimulated c-Jun NH(2)-terminal kinase (JNK) activation.

    Role of FGD1, a Cdc42 guanine nucleotide exchange factor, in epidermal growth factor-stimulated c-Jun NH2-terminal kinase activation and cell migration.
    Oshima T, Fujino T, Ando K, Hayakawa M.

    05/21/2011
    Mutations in the FGD1 gene is not associated with Aarskog syndrome.

    Familial syndrome resembling Aarskog syndrome.
    Xu M, Qi M, Zhou H, Yong J, Qiu H, Cong P, Hong X, Li C, Jiang Y, Chen X, Yu Y.

    11/27/2010
    analysis of nine novel mutations of the FGD1 gene in Aarskog-Scott syndrome

    Aarskog-Scott syndrome: clinical update and report of nine novel mutations of the FGD1 gene.
    Orrico A, Galli L, Faivre L, Clayton-Smith J, Azzarello-Burri SM, Hertz JM, Jacquemont S, Taurisano R, Arroyo Carrera I, Tarantino E, Devriendt K, Melis D, Thelle T, Meinhardt U, Sorrentino V.

    04/12/2010
    First case of the faciogenital dysplasia 1 (FGD1) gene in a patient with Aarskog-Scott syndrome.

    First case of deletion of the faciogenital dysplasia 1 (FGD1) gene in a patient with Aarskog-Scott syndrome.
    Bedoyan JK, Friez MJ, DuPont B, Ahmad A.

    01/21/2010
    FGD1 is preferentially associated with the trans-Golgi network (TGN), suggesting its involvement in export of proteins from the Golgi.

    Faciogenital dysplasia protein (FGD1) regulates export of cargo proteins from the golgi complex via Cdc42 activation.
    Egorov MV, Capestrano M, Vorontsova OA, Di Pentima A, Egorova AV, Mariggiò S, Ayala MI, Tetè S, Gorski JL, Luini A, Buccione R, Polishchuk RS., Free PMC Article

    01/21/2010
    Findings suggest a central role for Fgd1 in the focal degradation of the ECM in vitro and, for the first time, show a connection between Fgd1 and cancer progression, proposing that it might function during tumorigenesis.

    Faciogenital dysplasia protein Fgd1 regulates invadopodia biogenesis and extracellular matrix degradation and is up-regulated in prostate and breast cancer.
    Ayala I, Giacchetti G, Caldieri G, Attanasio F, Mariggiò S, Tetè S, Polishchuk R, Castronovo V, Buccione R.

    01/21/2010
    Brain cortex malformations such as PMG could be initiated by mutations in the evolutionary conserved RhoGEF domain of FGD1, by perturbing the signaling via Rho GTPases

    Unilateral focal polymicrogyria in a patient with classical Aarskog-Scott syndrome due to a novel missense mutation in an evolutionary conserved RhoGEF domain of the faciogenital dysplasia gene FGD1.
    Bottani A, Orrico A, Galli L, Karam O, Haenggeli CA, Ferey S, Conrad B.

    01/21/2010
    firstprevious page of 2 nextlast